The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1545
ISSUE1545
April 23, 2018
Nebulized Glycopyrrolate (Lonhala Magnair) for COPD
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Nebulized Glycopyrrolate (Lonhala Magnair) for COPD
April 23, 2018 (Issue: 1545)
The FDA has approved an inhalation solution
formulation of the long-acting antimuscarinic agent
(LAMA) glycopyrrolate (Lonhala Magnair – Sunovion)
for maintenance treatment of chronic obstructive
pulmonary disease (COPD). The new...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.